Same Science, Different Outcomes: The Trust Gap Your Competitors Are Closing
A 3-part workshop series for HealthTech CEOs and CMOs.
Two HealthTech companies with comparable clinical outcomes, and comparable technical depth. One becomes the category name investors and buyers reach for first. The other becomes the comparison slide in someone else's deck. What makes the difference?
Innovaccer and Arcadia, Komodo Health and Trilliant Health; the pattern repeats across the category: the best-told science wins, and most science-led teams are leaving that advantage on the table.
This three-part series is built for HealthTech CEOs and CMOs who've felt that gap between the strength of their evidence and the velocity of their commercial outcomes. We work through positioning, narrative, and the measurable business impact behind both.
June 10, 2026 - Workshop 1
The Trust Gap: Why Buyers Decide Before They Talk to You
Investors, payers, and enterprise buyers make decisions in this order: trust, narrative, evidence. Not the order most HealthTech teams build for. We open with a live self-diagnosis (you'll see your own gap in 90 seconds), then walk through evidence on how the modern B2B buyer actually moves.
June 16, 2026 - Workshop 2
The Cheapest Pipeline You'll Ever Build Is Already Inside Your Brand
June 18, 2026 - Workshop 3
From Vibes to Pipeline: A CEO's Operating Model for Tracking Brand & Thought Leadership ROI